Genetron Holdings Limited (NASDAQ:GTH – Get Free Report)’s share price was up 0.2% on Monday . The stock traded as high as $4.05 and last traded at $4.03. Approximately 412,600 shares changed hands during mid-day trading, an increase of 699% from the average daily volume of 51,662 shares. The stock had previously closed at $4.02.
Genetron Price Performance
The firm’s fifty day moving average is $3.95 and its 200-day moving average is $3.79.
Hedge Funds Weigh In On Genetron
A hedge fund recently bought a new stake in Genetron stock. Black Maple Capital Management LP bought a new stake in Genetron Holdings Limited (NASDAQ:GTH – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 158,112 shares of the company’s stock, valued at approximately $582,000. Black Maple Capital Management LP owned 0.50% of Genetron at the end of the most recent quarter. Institutional investors own 10.74% of the company’s stock.
About Genetron
Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services.
Featured Stories
- Five stocks we like better than Genetron
- Technology Stocks Explained: Here’s What to Know About Tech
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Merger or Not, Albertson’s Companies is a Good Buy
- How to Start Investing in Real Estate
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Genetron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetron and related companies with MarketBeat.com's FREE daily email newsletter.
